Canada - anglais - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 60mg - ziprasidone (ziprasidone hydrochloride monohydrate) 60mg - atypical antipsychotics

Canada - anglais - Health Canada

genmed a division of pfizer canada ulc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 80mg - ziprasidone (ziprasidone hydrochloride monohydrate) 80mg - atypical antipsychotics

Canada - anglais - Health Canada

auro pharma inc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 20mg - ziprasidone (ziprasidone hydrochloride monohydrate) 20mg - atypical antipsychotics

Canada - anglais - Health Canada

auro pharma inc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 40mg - ziprasidone (ziprasidone hydrochloride monohydrate) 40mg - atypical antipsychotics

Canada - anglais - Health Canada

auro pharma inc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 60mg - ziprasidone (ziprasidone hydrochloride monohydrate) 60mg - atypical antipsychotics

Canada - anglais - Health Canada

auro pharma inc - ziprasidone (ziprasidone hydrochloride monohydrate) - capsule - 80mg - ziprasidone (ziprasidone hydrochloride monohydrate) 80mg - atypical antipsychotics

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ziprasidone hydrochloride, quantity: 43.44 mg (equivalent: ziprasidone, qty 40 mg) - capsule, hard - excipient ingredients: titanium dioxide; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; gelatin; indigo carmine - for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ziprasidone hydrochloride, quantity: 86.88 mg (equivalent: ziprasidone, qty 80 mg) - capsule, hard - excipient ingredients: magnesium stearate; croscarmellose sodium; gelatin; indigo carmine; pregelatinised maize starch; colloidal anhydrous silica; titanium dioxide - for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ziprasidone hydrochloride, quantity: 65.16 mg (equivalent: ziprasidone, qty 60 mg) - capsule, hard - excipient ingredients: gelatin; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; titanium dioxide; pregelatinised maize starch - for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar i disorder.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ziprasidone hydrochloride, quantity: 21.72 mg (equivalent: ziprasidone, qty 20 mg) - capsule, hard - excipient ingredients: gelatin; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; indigo carmine; colloidal anhydrous silica; titanium dioxide - for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar i disorder.